Insider · CIK 0001319763

El Coronado Holdings, LLC

CIK 0001319763 Name as filed on the most recent filing

Filed as El Coronado Holdings, LLC (179)

341 transaction lines · from 179 filings · filed 2005-03-04 to 2014-02-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2007-06-06 P, Open-market purchase Novogen LtdNVGN 81,672, acquired Open Form 4 filing 0000943663-07-000275
2007-06-05 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 52,862, acquired Open Form 4 filing 0000943663-07-000268
2007-06-04 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 77,087, acquired Open Form 4 filing 0000943663-07-000268
2007-06-01 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 45,674, acquired Open Form 4 filing 0000943663-07-000260
2007-06-01 P, Open-market purchase Novogen LtdNVGN 74,119, acquired Open Form 4 filing 0000943663-07-000266
2007-05-31 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 102,668, acquired Open Form 4 filing 0000943663-07-000260
2007-05-30 P, Open-market purchase Novogen LtdNVGN 92,256, acquired Open Form 4 filing 0000943663-07-000258
2007-05-30 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 90,753, acquired Open Form 4 filing 0000943663-07-000254
2007-05-29 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 53,800, acquired Open Form 4 filing 0000943663-07-000254
2007-05-29 P, Open-market purchase Novogen LtdNVGN 17,138, acquired Open Form 4 filing 0000943663-07-000252
2007-05-25 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 51,994, acquired Open Form 4 filing 0000943663-07-000250
2007-05-25 P, Open-market purchase Novogen LtdNVGN 65,578, acquired Open Form 4 filing 0000943663-07-000252
2007-05-24 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 103,720, acquired Open Form 4 filing 0000943663-07-000250
2007-05-24 P, Open-market purchase Novogen LtdNVGN 91,100, acquired Open Form 4 filing 0000943663-07-000245
2007-05-23 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 16, acquired Open Form 4 filing 0000943663-07-000243
2007-05-23 P, Open-market purchase Novogen LtdNVGN 49,322, acquired Open Form 4 filing 0000943663-07-000245
2007-05-22 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 160,844, acquired Open Form 4 filing 0000943663-07-000243
2007-05-21 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 65,880, acquired Open Form 4 filing 0000943663-07-000238
2007-05-21 P, Open-market purchase Novogen LtdNVGN 74,178, acquired Open Form 4 filing 0000943663-07-000240
2007-05-18 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 5 lines 9,374, acquired Open Form 4 filing 0000943663-07-000238
2007-05-17 P, Open-market purchase Novogen LtdNVGN 47,330, acquired Open Form 4 filing 0000943663-07-000236
2007-05-17 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 71,357, acquired Open Form 4 filing 0000943663-07-000234
2007-05-16 P, Open-market purchase Novogen LtdNVGN 132,691, acquired Open Form 4 filing 0000943663-07-000236
2007-05-16 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 67,590, acquired Open Form 4 filing 0000943663-07-000234
2007-05-15 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 82,065, acquired Open Form 4 filing 0000943663-07-000225
2007-05-14 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 153,275, acquired Open Form 4 filing 0000943663-07-000225
2007-05-11 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 107,436, acquired Open Form 4 filing 0000943663-07-000219
2007-05-10 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 141,284, acquired Open Form 4 filing 0000943663-07-000219
2007-05-09 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 90,180, acquired Open Form 4 filing 0000943663-07-000217
2007-05-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 35,196, acquired Open Form 4 filing 0000943663-07-000217
2007-05-03 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 51,273, acquired Open Form 4 filing 0000943663-07-000213
2007-05-01 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 112,600, acquired Open Form 4 filing 0000943663-07-000198
2007-04-30 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 16,388, acquired Open Form 4 filing 0000943663-07-000180
2007-04-27 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 92,983, acquired Open Form 4 filing 0000943663-07-000180
2007-04-24 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 98,671, acquired Open Form 4 filing 0000943663-07-000170
2007-04-12 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 3 lines 50,195, acquired Open Form 4 filing 0000943663-07-000142
2007-04-10 P, Open-market purchase Novogen LtdNVGN 15,070, acquired Open Form 4 filing 0000943663-07-000123

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. El Coronado Holdings, LLC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001319763

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.